By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeoRx Corporation 

410 West Harrison Street

Seattle  Washington  98119-4007  U.S.A.
Phone: 206-281-7001 Fax: 206-284-7112




Searle  Development of plant-grown, human-like antibody for cancer treatment

Company News
The Day In Review: Merck & Co., Inc. (MRK) Heats Up The Statin Wars 6/19/2006 6:01:39 PM
NeoRx Corporation (NERX) (Poniard Pharmaceuticals, Inc.) Announces Treatment Of First Patient With Picoplatin In Phase 1/2 Front-Line Prostate Cancer Trial 5/31/2006 10:21:54 AM
NeoRx Corporation (NERX) (Poniard Pharmaceuticals, Inc.) Reports First Quarter Financial Results 5/16/2006 10:16:28 AM
The Day In Review: Immunomedics, Inc. (IMMU) Sells Cancer Drug For $183 Million 5/10/2006 5:08:26 PM
NeoRx Corporation (NERX) Initiates Clinical Trial Of Picoplatin In Colorectal Cancer And Announces Name Change To Poniard Pharmaceuticals, Inc. And Relocation Of Corporate Headquarters 5/10/2006 10:42:36 AM
NeoRx Corporation (NERX) Announces Participation In Upcoming Conferences 5/8/2006 10:58:51 AM
NeoRx Corporation (NERX) To Host Conference Call On May 10 To Provide Corporate And Picoplatin Clinical Development Updates 5/3/2006 12:31:14 PM
NeoRx Corporation (NERX) Closes $65 Million Financing Transaction 4/27/2006 11:43:20 AM
The Day In Review: Millipore Corporation (MIL) Buys Serologicals Corporation (SERO) For $1.4 Billion 4/25/2006 6:46:05 PM
NeoRx Corporation (NERX) Shareholders Approve Financing Transaction 4/25/2006 1:03:44 PM